Research Article
Discovery of Novel Biomarkers for Alzheimer’s Disease from Blood
Table 2
Performances of three proposed models in datasets GSE29676 and GSE39087.
| | Average LOOCV accuracy | Validation accuracy | Sensitivity | Specificity | NPV | PPV | FDR | FOR |
| Cross-validation in GSE29676 | ECH1 + NHLRC2 | 98.8% | 95.4% | 94.0% | 97.1% | 93.0% | 97.7% | 2.3% | 7.0% | ECH1 + HOXB7 | 97.7% | 95.6% | 95.0% | 96.3% | 94.1% | 97.1% | 2.9% | 5.9% | ERBB2 + FN1 + SLC6A13 | 96.5% | 89.6% | 87.9% | 91.8% | 86.4% | 93.4% | 6.6% | 13.6% | The Nagele model | 64.0% | 56.8% | 58.9% | 54.3% | 51.8% | 62.2% | 37.8% | 48.2% |
| Cross-validation in GSE39087 | ECH1 + NHLRC2 | 88.9% | 87.4% | 79.7% | 90.8% | 91.2% | 80.7% | 19.4% | 8.8% | ECH1 + HOXB7 | 97.8% | 96.9% | 96.8% | 96.9% | 98.6% | 93.8% | 6.2% | 1.4% | ERBB2 + FN1 + SLC6A13 | 74.4% | 69.8% | 80.9% | 65.0% | 89.4% | 51.4% | 48.6% | 10.6% | The Nagele model | 70.0% | 69.4% | 80.2% | 64.7% | 89.0% | 50.6% | 49.4% | 11.0% |
|
|